# US 2010/0166660 A1 · Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166660 A1
- Document ID: US20100166660A1
- Status: Published application
- Kind: A1
- Application number: 12/532,381
- Filed: 2008-03-21
- Published: 2010-07-01
- Earliest claimed: 2007-03-23
- Inventors: Frank Porreca; Todd W. Vanderah
- Web page: https://patentgrep.com/patent/US20100166660A1

## CPC

- A61K 49/0008: {Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention features animal models of migraine pain that can be used in a variety of ways, e.g., to identify compounds that reduce migraine pain or other migraine symptoms, to investigate behavioral changes correlated with the development and maintenance of a migraine-like state, and to better understand the mechanisms that underlie migraine pain.

## Claims

### Claim 1

A method for determining the propensity of a candidate compound to induce hyperalgesia in a human, said method comprising the steps of:
a) infusing said candidate compound into a non-human mammal for a period of at least 2 hours; and
b) applying a pain stimulus to said non-human mammal and determining said mammal's response,
wherein the threshold of pain for said non-human mammal is indicative of the propensity of said candidate compound to induce hyperalgesia in a human.

### Claim 2 (depends on 1)

The method of claim 1, wherein said non-human mammal is a rat.

### Claim 3 (depends on 1)

The method of claim 1, wherein said period is at least 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, or 24 hours.

### Claim 4 (depends on 1)

The method of claim 1, wherein said candidate compound is a compound that reduces migraine pain.

### Claim 5 (depends on 1)

The method of claim 1, wherein said pain stimulus is a von Frey filament.
